secwatch.observer — SEC 8-K summary
======================================

Issuer:     MERIT MEDICAL SYSTEMS INC (MMSI)
CIK:        0000856982
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0000856982-25-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Martha Aronson named CEO of Merit Medical as Fred Lampropoulos resigns; remains Chairman
--------------------------------------------------------------------------------

- Aronson appointed President and CEO effective Oct 3, 2025; Lampropoulos resigns as CEO but stays as director and Chairman.
- Aronson base salary $1M; signing bonus $250K; target bonus 100% of base; initial equity target $5.5M.
- Immediate equity grant of $4.125M in PSUs and RSUs; transition allowance $12K/month through Sep 2026.
- Lampropoulos serves as Executive Chairman through Jan 3, 2026, then non-employee director; consulting deal under negotiation.
- Board expanded from 10 to 11 to accommodate Aronson's appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000048/0000856982-25-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856982/000085698225000048/mmsi-20251003x8k.htm
  HTML page:      https://secwatch.observer/filing/0000856982-25-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer